108 related articles for article (PubMed ID: 30860475)
41. Genomic and transcriptomic profiles and in vitro resistance to mitoxantrone and idarubicin in pediatric acute leukemias.
Laskowska J; Lewandowska-Bieniek J; Szczepanek J; Styczyński J; Tretyn A
J Gene Med; 2016 Aug; 18(8):165-79. PubMed ID: 27280600
[TBL] [Abstract][Full Text] [Related]
42. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
[TBL] [Abstract][Full Text] [Related]
43. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
[TBL] [Abstract][Full Text] [Related]
44. mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death.
Cortez MA; Scrideli CA; Yunes JA; Valera ET; Toledo SR; Pavoni-Ferreira PC; Lee ML; Petrilli AS; Brandalise SR; Tone LG
Pediatr Blood Cancer; 2009 Dec; 53(6):996-1004. PubMed ID: 19672972
[TBL] [Abstract][Full Text] [Related]
45. P-glycoprotein (P-170) expression in acute leukemias.
Abd El-Ghaffar HA; Aladle DA; Farahat SE; Abd El-Hady N
Hematology; 2006 Feb; 11(1):35-41. PubMed ID: 16522547
[TBL] [Abstract][Full Text] [Related]
46. [ABC transporters' impact on effect and metabolism of drugs].
Slåtsve AM; Ravna AW; Lyså RA; Sager G
Tidsskr Nor Laegeforen; 2011 Jun; 131(11):1084-7. PubMed ID: 21681236
[TBL] [Abstract][Full Text] [Related]
47. Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines.
Tomiyasu H; Watanabe M; Sugita K; Goto-Koshino Y; Fujino Y; Ohno K; Sugano S; Tsujimoto H
Anticancer Res; 2013 Dec; 33(12):5317-23. PubMed ID: 24324065
[TBL] [Abstract][Full Text] [Related]
48. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
[TBL] [Abstract][Full Text] [Related]
49. Role of neuropilin-1 and its expression in Egyptian acute myeloid and acute lymphoid leukemia patients.
Younan S; Elhoseiny S; Hammam A; Gawdat R; El-Wakil M; Fawzy M
Leuk Res; 2012 Feb; 36(2):169-73. PubMed ID: 21978468
[TBL] [Abstract][Full Text] [Related]
50. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
51. Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all: comparison with MRD status after induction therapy.
Fedasenka UU; Shman TV; Savitski VP; Belevcev MV
Exp Oncol; 2008 Sep; 30(3):248-52. PubMed ID: 18806751
[TBL] [Abstract][Full Text] [Related]
52. Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance.
Annereau JP; Szakács G; Tucker CJ; Arciello A; Cardarelli C; Collins J; Grissom S; Zeeberg BR; Reinhold W; Weinstein JN; Pommier Y; Paules RS; Gottesman MM
Mol Pharmacol; 2004 Dec; 66(6):1397-405. PubMed ID: 15342794
[TBL] [Abstract][Full Text] [Related]
53. The overexpression of KIT proto-oncogene in acute leukemic cells is not necessarily caused by the gene mutation.
Szatkowski D; Hellmann A
Acta Haematol; 2015; 133(1):116-23. PubMed ID: 25247397
[TBL] [Abstract][Full Text] [Related]
54. Current Understanding of Interactions between Nanoparticles and ABC Transporters in Cancer Cells.
Yin J; Deng X; Zhang J; Lin J
Curr Med Chem; 2018; 25(42):5930-5944. PubMed ID: 29542407
[TBL] [Abstract][Full Text] [Related]
55. Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia.
Huang FF; Wu DS; Zhang L; Yu YH; Yuan XY; Li WJ; Chen XP; Zhao XL; Chen FP; Zeng H
Cancer Lett; 2013 Aug; 336(1):96-105. PubMed ID: 23603434
[TBL] [Abstract][Full Text] [Related]
56. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
57. Beclin-1 and hypoxia-inducible factor-1α genes expression: Potential biomarkers in acute leukemia patients.
Radwan SM; Hamdy NM; Hegab HM; El-Mesallamy HO
Cancer Biomark; 2016 Mar; 16(4):619-26. PubMed ID: 27002764
[TBL] [Abstract][Full Text] [Related]
58. Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE; Montesinos P; Herrero MJ; Moscardó F; Bosó V; Rojas L; Martínez-Cuadrón D; Hervás D; Boluda B; García-Robles A; Rodríguez-Veiga R; Martín-Cerezuela M; Cervera J; Sendra L; Sanz J; Miguel A; Lorenzo I; Poveda JL; Sanz MÁ; Aliño SF
Leuk Lymphoma; 2017 May; 58(5):1197-1206. PubMed ID: 27701910
[TBL] [Abstract][Full Text] [Related]
59. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
[TBL] [Abstract][Full Text] [Related]
60. Expression of the human major vault protein LRP in acute myeloid leukemia.
Hart SM; Ganeshaguru K; Scheper RJ; Prentice HG; Hoffbrand AV; Mehta AB
Exp Hematol; 1997 Nov; 25(12):1227-32. PubMed ID: 9357965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]